Century Health, a company specializing in AI-driven clinical data analysis, has successfully closed an oversubscribed $5 million seed funding round. The investment was led by Origin Ventures and will be used to enhance its AI platform and expand its data network. This capital infusion aims to accelerate the use of real-world evidence in therapeutic development for the life sciences industry.
Addressing a Critical Data Bottleneck
The field of clinical research has long been hindered by the immense challenge of processing unstructured data from electronic health records. Vital patient information is often trapped in formats like clinical notes and physician documentation, requiring slow and costly manual curation. This bottleneck significantly delays the generation of high-quality, research-ready evidence needed to advance new treatments and therapies.
Harnessing AI for High-Fidelity Data
To overcome this obstacle, Century Health developed its proprietary Century Health Abstraction & Retrieval Model (CHARM). This AI-powered platform automates the complex process of curating and enriching fragmented clinical data into structured, usable formats. The model has demonstrated remarkable precision, achieving 97% accuracy when validated against the rigorous standards of clinical expert judgment.
Fueling Growth and Strategic Expansion
The new funding will be instrumental in scaling the company's operations and deepening its impact across the life sciences sector. Century Health plans to expand its specialty provider data network, which grew 60-fold over the past year, and enhance its AI infrastructure. These efforts will support growing collaborations with partners, including several of the world's top five pharmaceutical companies.
Investor Confidence and Market Need
Prashant Shukla, Partner at lead investor Origin Ventures, highlighted the company's pivotal role in the industry's evolution. He stated that Century Health is accelerating medical breakthroughs by unlocking real-world data for both AI-driven discovery and demonstrating drug effectiveness. This dual utility creates a compelling value proposition for both healthcare providers and life sciences organizations.
Vish Srivastava, Co-Founder and CEO of Century Health, emphasized the transformative potential of automating data structuring. He noted that the funding enables the company to expand its network and generate critical evidence that shapes patient care. Srivastava affirmed that Century Health operates with the speed and clinical rigor the life sciences industry demands.
This $5 million seed round marks a significant milestone for Century Health, positioning it to address the growing demand for high-quality clinical data. By automating data curation, the company is set to play a crucial role in accelerating research and therapeutic development. The investment validates its vision of making real-world evidence a reliable and accessible resource for improving patient outcomes globally.